Literature DB >> 8079504

Identification of urinary metabolites of pyrilamine after oral administration to man.

B C Chung1, D H Kim, B H Jung, K Eom, W Slikker, J Park.   

Abstract

1. The metabolism of pyrilamine, 2-[4-methoxybenzyl-(2-dimethylaminoethyl) amino] pyridine, was studied in adult male volunteers after a single oral dose of 50 mg. 2. Solvent extracts of urine obtained with or without enzyme hydrolysis were analysed by gc/ms after derivatization with MSTFA/TMSCI (N-methyl-N-trimethylsilyl-trifluoroacetamide/trimethyl chlorosilane). The structure of metabolites were determined based on EI mass spectra and confirmed with those of authentic standards. 3. Conjugated metabolites identified in the urine were pyrilamine, O-desmethylpyrilamine, and ring hydroxylated derivatives of pyrilamine. O-desmethylpyrilamine was also detected in low abundance as a free form. 4. These metabolites observed in human urine were quite different from those previously reported in rat.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8079504     DOI: 10.3109/00498259409043248

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  2 in total

1.  Pharmacokinetic analysis of the FAK scaffold inhibitor C4 in dogs.

Authors:  John Wilton; Elena Kurenova; Laura Pitzonka; Allison Gaudy; Leslie Curtin; Sandra Sexton; William Cance; Gerald Fetterly
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-11-07       Impact factor: 2.441

Review 2.  Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions.

Authors:  R J Bertz; G R Granneman
Journal:  Clin Pharmacokinet       Date:  1997-03       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.